GALIMBERTI, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 38.110
NA - Nord America 35.754
AS - Asia 35.568
SA - Sud America 3.659
AF - Africa 767
OC - Oceania 340
Continente sconosciuto - Info sul continente non disponibili 33
Totale 114.231
Nazione #
US - Stati Uniti d'America 34.152
CN - Cina 11.202
SG - Singapore 10.483
GB - Regno Unito 10.291
IT - Italia 7.454
DE - Germania 4.443
RU - Federazione Russa 3.123
HK - Hong Kong 3.005
SE - Svezia 2.963
BR - Brasile 2.673
VN - Vietnam 2.600
FR - Francia 2.061
IN - India 1.956
BD - Bangladesh 1.717
NL - Olanda 1.633
IE - Irlanda 1.213
CA - Canada 1.127
TR - Turchia 1.091
UA - Ucraina 1.052
KR - Corea 971
FI - Finlandia 892
JP - Giappone 669
ID - Indonesia 543
ES - Italia 526
PL - Polonia 446
EU - Europa 376
CO - Colombia 360
DK - Danimarca 352
GR - Grecia 316
AU - Australia 299
BE - Belgio 292
MX - Messico 267
CI - Costa d'Avorio 252
AR - Argentina 242
AT - Austria 231
CH - Svizzera 212
IQ - Iraq 160
ZA - Sudafrica 129
IR - Iran 128
TW - Taiwan 105
PK - Pakistan 104
PT - Portogallo 104
PH - Filippine 96
RO - Romania 93
EC - Ecuador 89
UZ - Uzbekistan 86
CL - Cile 82
IL - Israele 79
MA - Marocco 72
MY - Malesia 69
NO - Norvegia 69
VE - Venezuela 68
SA - Arabia Saudita 67
CZ - Repubblica Ceca 64
EG - Egitto 63
JO - Giordania 62
PE - Perù 52
TH - Thailandia 51
TN - Tunisia 50
AE - Emirati Arabi Uniti 48
PY - Paraguay 43
KE - Kenya 42
NZ - Nuova Zelanda 39
JM - Giamaica 37
NP - Nepal 35
KZ - Kazakistan 34
RS - Serbia 34
LT - Lituania 33
DZ - Algeria 32
UY - Uruguay 32
LU - Lussemburgo 25
LB - Libano 24
CR - Costa Rica 23
AZ - Azerbaigian 22
SN - Senegal 22
HR - Croazia 20
DO - Repubblica Dominicana 19
HU - Ungheria 19
AL - Albania 18
BG - Bulgaria 18
NG - Nigeria 18
PA - Panama 18
HN - Honduras 17
LV - Lettonia 17
OM - Oman 17
GT - Guatemala 16
SK - Slovacchia (Repubblica Slovacca) 16
TT - Trinidad e Tobago 16
AM - Armenia 15
BO - Bolivia 15
ET - Etiopia 14
EE - Estonia 13
KG - Kirghizistan 13
KH - Cambogia 13
PR - Porto Rico 13
QA - Qatar 13
BA - Bosnia-Erzegovina 12
BY - Bielorussia 10
GE - Georgia 10
XK - ???statistics.table.value.countryCode.XK??? 10
Totale 114.332
Città #
Southend 8.610
Singapore 6.046
Ashburn 3.427
Hong Kong 2.683
San Jose 2.059
Chandler 2.021
Milan 1.925
Beijing 1.828
Seattle 1.534
Council Bluffs 1.290
Princeton 1.255
Dublin 1.161
Dallas 1.156
Wilmington 1.101
Fairfield 1.074
New York 968
Frankfurt am Main 906
Los Angeles 869
Santa Clara 822
Hefei 779
Ann Arbor 775
Ho Chi Minh City 772
Bengaluru 759
Jacksonville 755
Woodbridge 687
Hanoi 663
Nanjing 651
Houston 627
Lauterbourg 623
Cambridge 591
Guangzhou 528
Buffalo 474
Shanghai 462
Redmond 448
Dearborn 447
Toronto 445
Moscow 440
Des Moines 420
Berlin 413
Boardman 384
Jakarta 381
Tokyo 357
Warsaw 351
Mountain View 348
Redwood City 345
Helsinki 335
The Dalles 326
Somerville 291
Bogotá 284
Jinan 283
Serra 278
Sakarya 271
Andover 269
Rome 264
São Paulo 259
Abidjan 251
Ottawa 249
Phoenix 246
Munich 232
Hangzhou 231
Tianjin 229
Shenyang 228
Cangzhou 223
Nuremberg 219
Columbus 217
Kent 207
Athens 202
Seoul 191
Istanbul 187
Changsha 180
London 177
Chicago 168
Nanchang 156
Brussels 151
Turin 137
Hanover 132
Hebei 132
Amsterdam 124
Da Nang 124
Shenzhen 123
Zhengzhou 123
Naples 122
Haiphong 119
Fuzhou 118
Atlanta 117
Norwalk 110
Vienna 107
San Francisco 106
Parma 102
San Diego 102
Wuhan 99
Montreal 97
Washington 97
Paris 93
Rio de Janeiro 92
Boston 90
Chengdu 89
Jiaxing 87
Bologna 86
Madrid 86
Totale 64.278
Nome #
A second update on mapping the human genetic architecture of COVID-19 1.479
Mapping the human genetic architecture of COVID-19 1.116
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 1.088
Fluid biomarkers in frontotemporal dementia: Past, present and future 1.088
Serum neurofilament light chain in genetic frontotemporal dementia : a longitudinal, multicentre cohort study 914
Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder 574
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis? 530
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 526
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 514
Frontotemporal dementia: from genetics to therapeutic approaches 484
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression 469
Epigenetic modulation of BDNF gene in patients with major depressive disorder 464
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis 436
Heterozygous TREM2 mutations in frontotemporal dementia 420
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 402
Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion : a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits 402
New insights into the genetic etiology of Alzheimer's disease and related dementias 401
Age at symptom onset and death and disease duration in genetic frontotemporal dementia : an international retrospective cohort study 385
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease 369
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility 365
Psychiatric Disorders in Alzheimer Disease With the Presenilin-1 L226F Mutation 352
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? 347
Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses 340
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease 336
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 332
Lag-time in Alzheimer's disease patients: A potential plasmatic oxidative stress marker associated with ApoE4 isoform 332
A functional variant in ERAP1 predisposes to multiple sclerosis 330
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 327
Influence of the Glu298Asp polymorphism of NOS3 on age at aonset and homocysteine levels in AD patients 325
Frontotemporal dementia and its subtypes: a genome-wide association study 322
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 311
Rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells in Patients with Alzheimer’s Disease 305
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 298
NOS3 Glu298Asp polymorphism is a risk factor for frontotemporal lobar degeneration 295
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 293
Weight loss predicts progression of mild cognitive impairment to Alzheimer's disease 292
Usefulness of multi-parametric MRI for the investigation of posterior cortical atrophy 292
Vascular risk factors do not individually effect risk of conversion of mild cognitive impairment to dementia. 286
The T-786C NOS3 polymorphism in Alzheimer's disease : association and influence on gene expression 285
Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism 284
Role of hnRNP-A1 and miR-590-3p in neuronal death : genetics and expression analysis in patients with Alzheimer’s disease and frontotemporal lobar degeneration 283
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk 281
The Enigmatic Role of Viruses in Multiple Sclerosis : Molecular Mimicry or Disturbed Immune Surveillance? 277
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 277
Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy 276
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia 273
Progranulin gene mutation scanning in Alzheimer's disease and frontotemporal lobar degeneration: functional and phenotypic correlations. 271
Gender effects on plasma PGRN levels in patients with Alzheimer's disease : a preliminary study 267
CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration 267
Changes in vitamin B12 and tumour necrosis factor-a levels in cerebrospinal fluid of patients with different subtypes of multiple sclerosis 266
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 266
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis 263
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 263
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 263
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis 258
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 258
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 258
Cerebrospinal fluid glutamate changes in functional movement disorders 258
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease 257
Transcranial direct current stimulation modulates cortical neuronal activity in Alzheimer's disease 257
Association of Changes in Cerebral and Hypothalamic Structure With Sleep Dysfunction in Patients With Genetic Frontotemporal Dementia 256
Causal frontotemporal de generation mutations : a novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 255
Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease 255
Total homocysteine levels in AD patients : analysis on different onset subgroups 254
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status 254
A "Candidate-Interactome" Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis 254
E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis 253
Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions : Frequency in a cohort of geriatric non-demented subjects 253
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease 253
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males 252
A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease 251
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease 251
Pin1 contribution to Alzheimer's disease : transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease 251
Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation 251
Novel exon 1 progranulin gene variations in Alzheimer's disease and frontotemporal lobar degeneration 250
Progress in Alzheimer's disease research in the last year 249
Exosome determinants of physiological aging and age-related neurodegenerative diseases 249
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 249
Genetic and functional analysis of progranulin gene variants in Alzheimer's disease. 248
GRN variability contributes to sporadic frontotemporal lobar degeneration 248
Repetitive element hypermethylation in multiple sclerosis patients 247
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 247
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 246
DNA methylation in repetitive elements and Alzheimer disease 245
IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment 244
Low dose-topiramate-induced acute bilateral reversible glaucoma : a case report 243
Novel exon 1 progranulin gene variant in Alzheimer’s disease 243
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 241
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 241
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia 241
Diogenes syndrome in dementia: a case report 241
Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes 240
Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation 237
The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment 236
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 235
Validation of the Italian Addenbrooke’s cognitive examination revised (ACE-R) as a screening test 235
TREM2 regulates microglial cell activation in response to demyelination in vivo 235
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 234
Loss of cobalamin-mediated regulation leads to decreased EGF and increased soluble CD40 levels in cerebrospinal fluid of patients with multiple sclerosis 231
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis 231
Totale 33.878
Categoria #
all - tutte 346.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 346.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.027 0 0 0 0 0 0 0 0 0 0 1.315 712
2021/20227.109 558 341 275 358 521 397 651 433 891 732 535 1.417
2022/20239.790 1.220 862 761 961 1.041 1.770 345 615 1.092 274 547 302
2023/20247.754 331 544 455 512 1.812 572 511 435 277 568 790 947
2024/202518.567 661 1.838 518 1.744 1.464 927 942 1.882 1.187 1.853 1.689 3.862
2025/202638.094 3.611 2.618 3.720 3.125 3.467 2.629 4.916 2.390 4.469 2.913 4.236 0
Totale 119.330